Europe
Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, and the renowned University of Utah have published scientific investigations that provide initial evidence for further significant benefits of the innovative Marinosolv® platform in the field of corneal eye diseases.
Summit Therapeutics plc announced that it achieved the first milestone under its license and collaboration agreement with Eurofarma Laboratórios SA.
Funding to support GMP adenovirus manufacture for a first-in-human basket clinical trial in melanoma, lung cancer, and triple negative breast cancer
Delivering an efficient, seamless process for clinical labels from protocol to print
Biotechnology company, Cellexus International Ltd, have added a new product to their range of patented CellMaker single-use airlift bioreactor systems.
This partnership with the AP-HM could lead to a world first and opens up important applications in the field of regenerative medicine.
Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community
A clearer picture of how DNA changes lead to cancer has emerged, following the most comprehensive evaluation of non-coding driver mutations to date by researchers at the Wellcome Sanger Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, Aarhus University Hospital and their collaborators.
Valeritas and its subsidiaries filed for Chapter 11 bankruptcy on February 9, 2020 in the District of Delaware. At the same time, Zealand entered into the definitive deal to buy the assets.
Pharma and biotech companies strengthen their leadership teams and boards with this weeks appointments.
PRESS RELEASES